Premarket Decliner
BRTX Biorestorative Therapies3.45+0.65+23.2%
Premarket:1.60-1.85 (-53.6%)
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
Globe NewswireTue, 6-Feb 8:05 AM
Premarket Gainer
BRTX Biorestorative Therapies4.57-0.07-1.5%
Premarket:6.78+2.21 (+48.4%)
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Globe NewswireTue, 21-Dec 4:01 PM
After Hours Gainer
After Hours:6.70+2.13 (+46.6%)
After Hours:6.06+1.49 (+32.6%)
BRTX Biorestorative Therapies5.81-0.19-3.2%
Premarket:6.40+0.59 (+10.2%)
BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
Globe NewswireThu, 2-Dec 6:00 AM
